Hepatocellular carcinoma: signaling pathways and therapeutic advances

Regulation of cGAS–STING signalling and its diversity of cellular outcomes

ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response

Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets